Review
Published on 13 Nov 2023
FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1278056
- 1,985 views
- 4 citations
Type at least 3 characters
2,597 articles
Articles
Review
Published on 13 Nov 2023
Resistance to immune checkpoint inhibitors in gastric cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1285343
- 3,127 views
- 4 citations
Original Research
Published on 13 Nov 2023
Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1253169
- 2,035 views
- 4 citations
Original Research
Published on 13 Nov 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1269935
- 1,636 views
- 2 citations
Review
Published on 10 Nov 2023
Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1287505
- 3,531 views
- 12 citations
Systematic Review
Published on 09 Nov 2023
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1255158
- 2,684 views
- 7 citations
Review
Published on 09 Nov 2023
NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1291773
- 2,395 views
- 3 citations
Case Report
Published on 09 Nov 2023
Case report: the dissociated response and clinical benefit of primary leiomyosarcoma of the bone treated with penpulimab plus lenvatinib after failed multi-line therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1239699
- 1,447 views
Original Research
Published on 09 Nov 2023
Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1288883
- 2,100 views
- 3 citations
Original Research
Published on 08 Nov 2023
The platinum coordination complex inhibits cell invasion-migration and epithelial-to-mesenchymal transition by altering the TGF-β-SMAD pathway in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1178190
- 1,444 views
- 2 citations
Original Research
Published on 08 Nov 2023
Multi-omics analysis reveals CLIC1 as a therapeutic vulnerability of gliomas
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1279370
- 2,205 views
- 1 citation
Systematic Review
Published on 07 Nov 2023
Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1284240
- 2,135 views
Original Research
Published on 07 Nov 2023
MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1285799
- 1,749 views
- 1 citation
Editorial
Published on 07 Nov 2023
Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1320139
- 732 views
Original Research
Published on 06 Nov 2023
Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1271435
- 2,367 views
- 7 citations
Original Research
Published on 02 Nov 2023
Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1290255
- 2,990 views
- 4 citations